What is Mydayis?
Mydayis (Generic Name: mixed salts of a single-entity amphetamine product) is an ADHD medication with a long-acting, triple-bead, mixed amphetamine salts formulation used for once-daily treatment of attention deficit hyperactivity disorder (ADHD or ADD) in adolescents and adults ages 13 and older. According to the FDA, Mydayis is a federally controlled substance (CII) because it can be abused or lead to dependence. It is an amphetamine.
It may improve focus for people with inattentive ADHD, and decrease impulsivity and hyperactive behavior — hallmark ADHD symptoms for many patients.
WHAT DRUGS DOES IT INTERACT WITH?
Mydayis may interact with acidifying or alkalinizing agents (GI and urinary), monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John’s wort, quinidine, ritonavir, omeprazole, esomeprazole, pantoprazole, and cimetidine. Tell your doctor all medications and supplements you use.
Common side effects of Mydayis include:
- decreased appetite,
- decreased weight,
- dry mouth,
- increased heart rate,
- feeling jittery,
- tooth grinding,
- menstrual pain or cramping, and
- erectile dysfunciton.